These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36997217)

  • 1. GPs' willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions.
    Lloyd KE; Hall LH; Ziegler L; Foy R; Borthwick GM; MacKenzie M; Taylor DG; Smith SG;
    Br J Gen Pract; 2023 Apr; 73(729):e302-e309. PubMed ID: 36997217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey.
    Smith SG; Foy R; McGowan J; Kobayashi LC; Burn J; Brown K; Side L; Cuzick J
    Fam Cancer; 2017 Oct; 16(4):509-516. PubMed ID: 28434157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes.
    Smith SG; Foy R; McGowan JA; Kobayashi LC; de Censi A; DeCensi A; Brown K; Side L; Cuzick J
    Br J Gen Pract; 2017 Jun; 67(659):e414-e427. PubMed ID: 28193617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providers.
    Lloyd KE; Foy R; Hall LH; Ziegler L; Green SMC; Haider ZF; Taylor DG; MacKenzie M; Smith SG
    Hered Cancer Clin Pract; 2022 Aug; 20(1):30. PubMed ID: 35999639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
    Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
    Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
    Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.
    Serrano D; Patrignani P; Stigliano V; Turchetti D; Sciallero S; Roviello F; D'Arpino A; Grattagliano I; Testa S; Oliani C; Bertario L; Bonanni B
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
    Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward RL; Goodwin A; Macrae F; Hiller J; Trainer AH; Mitchell G
    Fam Cancer; 2017 Jan; 16(1):99-109. PubMed ID: 27677266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
    Burn J; Mathers J; Bishop DT
    Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention in Lynch syndrome.
    Burn J; Mathers JC; Bishop DT
    Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care.
    Nguyen P; McIntosh J; Bickerstaffe A; Maddumarachchi S; Cummings KL; Emery JD
    Br J Gen Pract; 2019 Dec; 69(689):e843-e849. PubMed ID: 31740461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
    Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
    Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome: history, causes, diagnosis, treatment and prevention (CAPP2 trial).
    Burn J; Mathers J; Bishop DT
    Dig Dis; 2012; 30 Suppl 2():39-47. PubMed ID: 23207931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness of French General Practitioners to Prescribe mHealth Apps and Devices: Quantitative Study.
    Della Vecchia C; Leroy T; Bauquier C; Pannard M; Sarradon-Eck A; Darmon D; Dufour JC; Preau M
    JMIR Mhealth Uhealth; 2022 Feb; 10(2):e28372. PubMed ID: 35147508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.
    Short D; Frischer M; Bashford J; Ashcroft D
    BMC Fam Pract; 2003 Jul; 4():9. PubMed ID: 12871601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
    Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
    N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study exploring how GPs decide to prescribe antidepressants.
    Hyde J; Calnan M; Prior L; Lewis G; Kessler D; Sharp D
    Br J Gen Pract; 2005 Oct; 55(519):755-62. PubMed ID: 16212850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial.
    Milton S; McIntosh J; Macrae F; Chondros P; Trevena L; Jenkins M; Walter FM; Taylor N; Boyd L; Saya S; Karnchanachari N; Novy K; Forbes C; Gutierrez JM; Broun K; Whitburn S; McGill S; Fishman G; Marker J; Shub M; Emery J
    Trials; 2021 Jul; 22(1):452. PubMed ID: 34266464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and evaluation of a computerised decision support system for primary care based upon 'patient profile decision analysis'.
    Short D; Frischer M; Bashford J
    Inform Prim Care; 2003; 11(4):195-202. PubMed ID: 14980058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.